Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker

Background: A subgroup of patients with acute kidney injury (AKI) do not fulfil the functional criteria for AKI diagnosis but show elevated levels of new biomarkers reflecting tubular injury, suggesting that these patients suffer “subclinical AKI”. We investigated the incidence and possible implicat...

Full description

Bibliographic Details
Main Authors: Lior Lupu, Keren-Lee Rozenfeld, David Zahler, Samuel Morgan, Ilan Merdler, Moshe Shtark, Ilana Goldiner, Shmuel Banai, Yacov Shacham
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/10/2120
_version_ 1797534112130531328
author Lior Lupu
Keren-Lee Rozenfeld
David Zahler
Samuel Morgan
Ilan Merdler
Moshe Shtark
Ilana Goldiner
Shmuel Banai
Yacov Shacham
author_facet Lior Lupu
Keren-Lee Rozenfeld
David Zahler
Samuel Morgan
Ilan Merdler
Moshe Shtark
Ilana Goldiner
Shmuel Banai
Yacov Shacham
author_sort Lior Lupu
collection DOAJ
description Background: A subgroup of patients with acute kidney injury (AKI) do not fulfil the functional criteria for AKI diagnosis but show elevated levels of new biomarkers reflecting tubular injury, suggesting that these patients suffer “subclinical AKI”. We investigated the incidence and possible implications of “subclinical AKI”, compared to no and clinical AKI among ST elevation myocardial infarction patients (STEMI) treated with primary coronary intervention (PCI). Methods: We included 223 patients with STEMI treated with PCI. Neutrophil gelatinase-associated lipocalin (NGAL) was used as a marker of renal tubular damage in the absence of functional AKI, with NGAL levels ≥100 ng/mL suggesting subclinical AKI. Patients were assessed for the occurrence of in-hospital adverse outcomes. Results: Of the study patients, 45 (25%) had subclinical AKI. These patients were more likely to have left ventricular ejection fraction ≤45% (33% vs. 23%. <i>p</i> = 0.01), in-hospital adverse outcomes (73% vs. 48%; <i>p</i> = 0.005), and a combination of the two. The multivariate regression model demonstrated that subclinical AKI was independently associated with in-hospital adverse outcomes (OR 3.71, 95% CI 1.30–10.62, <i>p</i> = 0.02). Conclusions: Subclinical AKI is common among STEMI patients and is independently associated with adverse outcomes, even in the absence of functional AKI.
first_indexed 2024-03-10T11:25:01Z
format Article
id doaj.art-96174b6a9cf7426782a2080af8eecf33
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-10T11:25:01Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-96174b6a9cf7426782a2080af8eecf332023-11-21T19:43:18ZengMDPI AGJournal of Clinical Medicine2077-03832021-05-011010212010.3390/jcm10102120Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal BiomarkerLior Lupu0Keren-Lee Rozenfeld1David Zahler2Samuel Morgan3Ilan Merdler4Moshe Shtark5Ilana Goldiner6Shmuel Banai7Yacov Shacham8Department of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelDepartment of Cardiology, Tel-Aviv Sourasky Medical Center affiliated to the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 64239, IsraelBackground: A subgroup of patients with acute kidney injury (AKI) do not fulfil the functional criteria for AKI diagnosis but show elevated levels of new biomarkers reflecting tubular injury, suggesting that these patients suffer “subclinical AKI”. We investigated the incidence and possible implications of “subclinical AKI”, compared to no and clinical AKI among ST elevation myocardial infarction patients (STEMI) treated with primary coronary intervention (PCI). Methods: We included 223 patients with STEMI treated with PCI. Neutrophil gelatinase-associated lipocalin (NGAL) was used as a marker of renal tubular damage in the absence of functional AKI, with NGAL levels ≥100 ng/mL suggesting subclinical AKI. Patients were assessed for the occurrence of in-hospital adverse outcomes. Results: Of the study patients, 45 (25%) had subclinical AKI. These patients were more likely to have left ventricular ejection fraction ≤45% (33% vs. 23%. <i>p</i> = 0.01), in-hospital adverse outcomes (73% vs. 48%; <i>p</i> = 0.005), and a combination of the two. The multivariate regression model demonstrated that subclinical AKI was independently associated with in-hospital adverse outcomes (OR 3.71, 95% CI 1.30–10.62, <i>p</i> = 0.02). Conclusions: Subclinical AKI is common among STEMI patients and is independently associated with adverse outcomes, even in the absence of functional AKI.https://www.mdpi.com/2077-0383/10/10/2120neutrophil gelatinase-associated lipocalinST-segment elevation myocardial infarctionrenal injury
spellingShingle Lior Lupu
Keren-Lee Rozenfeld
David Zahler
Samuel Morgan
Ilan Merdler
Moshe Shtark
Ilana Goldiner
Shmuel Banai
Yacov Shacham
Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker
Journal of Clinical Medicine
neutrophil gelatinase-associated lipocalin
ST-segment elevation myocardial infarction
renal injury
title Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker
title_full Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker
title_fullStr Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker
title_full_unstemmed Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker
title_short Detection of Renal Injury Following Primary Coronary Intervention among ST-Segment Elevation Myocardial Infarction Patients: Doubling the Incidence Using Neutrophil Gelatinase-Associated Lipocalin as a Renal Biomarker
title_sort detection of renal injury following primary coronary intervention among st segment elevation myocardial infarction patients doubling the incidence using neutrophil gelatinase associated lipocalin as a renal biomarker
topic neutrophil gelatinase-associated lipocalin
ST-segment elevation myocardial infarction
renal injury
url https://www.mdpi.com/2077-0383/10/10/2120
work_keys_str_mv AT liorlupu detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker
AT kerenleerozenfeld detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker
AT davidzahler detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker
AT samuelmorgan detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker
AT ilanmerdler detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker
AT mosheshtark detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker
AT ilanagoldiner detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker
AT shmuelbanai detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker
AT yacovshacham detectionofrenalinjuryfollowingprimarycoronaryinterventionamongstsegmentelevationmyocardialinfarctionpatientsdoublingtheincidenceusingneutrophilgelatinaseassociatedlipocalinasarenalbiomarker